Response letter to ‘does high LDL-cholesterol cause cardiovascular disease?’

Autor:	Ralf Sundberg, Harumi Okuyama, Luca Mascitelli, Paul J. Rosch, Malcolm Kendrick, Kilmer S. McCully, Peter H Langsjoen, Björn Hammarskjöld, Tomohito Hamazaki, Michel de Lorgeril, Rokuro Hama, Tore Scherstén, David M. Diamond, Niamh Hynes, Sherif Sultan, Uffe Ravnskov
Rok vydání:	2019
Předmět:	Ldl cholesterol Cholesterol business.industry MEDLINE General Medicine Disease Bioinformatics 030226 pharmacology & pharmacy 03 medical and health sciences Hydroxymethylglutaryl-CoA Reductase Inhibitors chemistry.chemical_compound 0302 clinical medicine chemistry 030220 oncology & carcinogenesis Medicine Pharmacology (medical) General Pharmacology Toxicology and Pharmaceutics business
Zdroj:	Expert Review of Clinical Pharmacology. 12:93-94
ISSN:	1751-2441 1751-2433
DOI:	10.1080/17512433.2019.1561102
Popis:	We thank the authors for their interest in our paper and wish to expand upon the issues they raised in their letter. Our paper presents strong arguments against the general view that high LDL-chole...
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::c31f60d1ff480d0c79fa0dadc1f0956a https://doi.org/10.1080/17512433.2019.1561102 Zobrazit plný text záznamu